Drug Profile
Research programme: proto oncogene protein B-raf inhibitors - GlaxoSmithKline
Alternative Names: SB-590885Latest Information Update: 18 Apr 2011
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Class Imidazoles; Small molecules
- Mechanism of Action Proto oncogene protein b raf inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Solid tumours
Most Recent Events
- 07 May 2005 Preclinical trials in Solid tumours in United Kingdom (unspecified route)
- 07 May 2005 Preclinical trials in Solid tumours in USA (unspecified route)